Trevi Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 917,380 | 1.19% |
Hedge Funds | 9,426,931 | 12.3% |
General Public | 17,774,198 | 23.1% |
VC/PE Firms | 18,751,466 | 24.4% |
Institutions | 29,995,736 | 39% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,370,376 | US$33.1m | 0% | 1.4% | |||
7,381,090 | US$21.5m | 0% | 0.82% | |||
5,026,931 | US$14.6m | 0% | 0.2% | |||
4,400,000 | US$12.8m | 0% | 0.04% | |||
3,422,656 | US$10.0m | 0% | 0.45% | |||
3,262,381 | US$9.5m | 33.8% | no data | |||
3,221,752 | US$9.4m | 2.76% | no data | |||
2,750,000 | US$8.0m | -1.79% | 0.9% | |||
2,567,990 | US$7.5m | -2.91% | 1.09% | |||
1,612,903 | US$4.7m | 0% | 0.37% | |||
1,538,517 | US$4.5m | 1.88% | 0.68% | |||
1,327,285 | US$3.9m | 0.67% | 0.03% | |||
1,322,800 | US$3.8m | -10.3% | 1.31% | |||
1,264,166 | US$3.7m | 10.2% | no data | |||
952,912 | US$2.8m | 5.9% | no data | |||
750,000 | US$2.2m | -46.1% | 1.32% | |||
606,227 | US$1.8m | 0% | 0.01% | |||
482,575 | US$1.4m | -42.8% | 0.31% | |||
433,642 | US$1.3m | 35.1% | no data | |||
424,725 | US$1.2m | -29.9% | 0.11% | |||
352,489 | US$1.0m | 0% | no data | |||
290,500 | US$845.4k | 11.7% | 0.68% | |||
250,000 | US$727.5k | -50% | 0.34% | |||
241,613 | US$703.1k | -40.5% | 0.31% | |||
220,315 | US$641.1k | 2.74% | no data |